Summary: Excitatory amino acids (glutamate, aspartate) play an important role in the ischemic cascade leading to cell death. The N-methyl-D-aspartate (NMDA) receptor is an excitatory amino acid (EAA) receptor, and NMDA receptor antagonists have been shown to exert a neuroprotective effect in central nervous system ischemia. The purpose of this study was to investigate the effects of noncompetitive NMDA receptor antagonists MK-801 and to observe the changes in EAAs after spinal cord ischemia in a rabbit model. Spinal cord ischemia was induced by clamping the infrarenal abdominal aorta for 24 min. Group 1 (n=6) received no pharmacologic infusion. Group 2 (n=5) was administered an intra-aortic hypothermic MK-801 (1 mg/kg) solution and group 3 (n=6) was administered an intra-aortic normothermic MK-801 (2 mg/kg) solution immediately after clamping of the abdominal aorta. We evaluated the neurological function at 12, 24 and 48 hrs after spinal cord ischemia. A histopathologic study was carried out 72 hrs after spinal cord ischemia, and the results for groups 1 and 3 were compared. The glutamate and aspartate levels in the blood plasma were compared at pre-ischemia and at 12, 24, and 48 hrs among the groups. The perfusion of a normothermic MK-801 (2 mg/kg) solution significantly reduced the neurological dysfunction and the neuronal damage. There was a significant increase in aspartate at 24 and 48 hrs in group 1, but no such increase in glutamate occurred in groups 1 and 3. In conclusion, these data provide the evidence that therapeutic intervention with MK-801 (2 mg/kg) in the early period of spinal cord ischemia is beneficial in reducing neurological dysfunction and neuronal damage.
INTRODUCTION
Spinal cord ischemic injury, particularly paraplegia, can occur during operations of the descending and thoracoabdominal aorta and is an extremely serious complication. The complication rate ranges from 5 to 30% [1] . Spinal cord ischemic injury can be caused by a number of factors, including hypoperfusion of spinal cord tissue, thromboembolism of the critical intercostal arteries, and reperfusion injury in the perioperative period [2] . Many. surgical and pharmacological attempts have been made to prevent this complication, but as of yet there are no reliable methods for avoiding spinal cord ischemic injury [1, 3] .
Glutamate and aspartate are an important neurotransmitter in the central nervous system (CNS) and is thought to be an excitatory neurotransmitter [4, 5] . Excessive glutamate accumulation in theischemic condition has been observed to be a neurotoxic agent. Therefore, glutamate is generally said to be an excitotoxic amino acid [6] . The N-methyl-D-aspartate (NMDA) receptor is most likelyto be involved in ischemic neuronal injury [7] . After spinal cord ischemia, the activation of NMDAreceptors and the subsequent induction of excessive calcium ion influx can lead to neuronal death [6, 7] . NMDA receptor antagonists have been shown to reduce spinal cord injury after CNS ischemia in both in vivo and ivitro studies [4] [5] [6] [7] . The present study was designed to examine the neuroprotective effects of noncompetitive NMDA receptor antagonist MK-801 [(+)-5-methyl-10, 1 1 -dihydro-5H-dibenzo [ A median laparotomy was performed. We then injected 150 units/kg of the heparin intravenously for systemic anticoagulation. Spinal cord ischemia was induced by clamping the infra renal abdominal aorta, the bilateral common iliac artery, and the posterior mesenteric artery for 24 min (Fig. 1) .The rabbits were divided into three groups: in group 1 (n=6), to administer the MK-801 solution (Fig. 1) . After declamping, the 24-gauge catheter was removed, and the arteriotomy was closed with 7-0 polypropylene, after which the laparotomy incision was closed. The rabbits were then returned to their cages and allowed free access to water and food. The neurological status was scored by a Modified Tarlov scale ( After 72 hrs, all animals were anesthetized again, and their spinal cords were fixed with 10% formaldehyde solution (total 100 ml) perfusing through the abdominal aorta. The lumbosacral cordswere removed and stored in 10% formaldehyde solution for 3 days. After alcohol dehydration and paraffin embedding, sections were cut 5 am thick and stained with hematoxvlin and eosin.
We selected six sections at the L-6 level from each rabbit and counted the number of surviving neurons on both sides of the ventral horn per section. For the histopathologic grading of neuronaldamage, we counted the mean number of surviving neurons within the range of a rectangular area (Fig. 2) . Spinal cord tissues from three normal rabbits were sectioned and used to compare with the number of motor neurons in the ventral horn in groups 1 and 3.
Excitatory amino acid analysis
We compared the time course of changes in the blood plasma levels of amino acids (glutamate, aspartate) at the pre-ischemic period and following 12, 24, and 48 hrs after spinal cord ischemia in both groups 1 and 3. Blood plasma samples were separated for electrochemical detection using ahighspeed amino acid analyzer by the ninhydrin method (HITACHI L-8500 Amino Acid Analyzer).
Statistical analysis
For the statistical assessment of neurological changes, we used the Mann-Whitney U test analysis of variance to determine the significant differences among the 3 groups.
The numbers of surviving neurons and the excitatory amino acid levels in the two groups were analyzed by an unpaired Students t test. A p value of <0.05 was considered significant.
RESULTS
All animals survived for 72 hrs after spinal cord ischemia. In all three groups, the preoperativestatus, body weights (Table 1) , intraoperative rectal temperatures (Fig. 3) , and doses of anesthetic agents were not significantly different. . There was no change in neurological function between 48 and 72 hrs after spinal cord ischemia in any of the rabbits. In group 1, 5 of 6 rabbits had paraplegia (Tarlov scale of 0), while 1 of 6rabbits exhibited severe paraparesis (Tarlov scale of 1) at 48 hrs after spinal cord ischemia. In group 2, 3 of 5 rabbits had paraplegia (Tarlov scale of 0), and 2 of 5 rabbits exhibited severe paraparesis (Tarlov scale of 1-2) at 48 hrs. In groups 1 and 2, 1 of 6 rabbits (group 1) had delayed-on set paraplegia and the other 10 rabbits developed progressive paraplegia or severe paraparesis from which they were not able to recover. There were no significant differences between groups 1 and 2 at any period after spinal cord ischemia (12h: p=0.2245, 24h: p=0.1274, 48h: p=0.4094).
In group 3 (n=6), 5 of 6 animals recovered fully (Tarlov scale of 5), 1 of 6 animals had slight paraparesis (Tarlov scale of 4) at 48 hrs after spinal cord ischemia. None of the rabbits in group 3 showed paraplegia at 48 hrs. In group 3, until 12 hrs after spinal cord ischemia, 5 of 6 rabbits developed either slight or severe paraparesis (Tarlov scale of 1-2-3), while 1 of 6 rabbits were intact. At 24 hrs after spinal cord ischemia, the other 4 of 5 rabbits had fully recovered, with a Tarlov scale of 4-5. Therefore, there were no significant differences in neurological status between groups 1 and 3 at 12 hrs after spinal cord ischemia (p> 0.9999); at24 and 48 hrs, however, significant differences were observed (24h: p=0.0032, 48h: p=0.0019). were primarily limited to the gray matter, and in group 1 these areas showed a significant loss of neurons (Fig. 5) . The most severe changes were found in the segments L-5 to L-6. Edema, and vacuolization were remarkable in the anterior horn. The cells were round, and the surrounding white matter was edematous in the rabbits with complete paraplegia. On the other hand, in group 3 rabbits, motor neurons in the anterior horn were preserved well (Fig. 6) , similar to the spinal cord tissue of normal rabbits (Fig. 7 ). 
EAA analysis
The results of the blood plasma analysis for EAAs are shown in Table 3 (A, B). In group 1, there were significant differences in the elevation of aspartate between the levels observed at 12 and 48 hrs (p=0.0124), and at 24 and 48 hrs (p=0.0132). There were no significant differences, however, in the elevations of glutamate at any period. The glutamate and aspartate levels were notsignificantly elevated between 24 and 48 hrs in group 3. In group 1, there were significant differences in the elevation of aspartate between the levels observed at 12 and 48 hrs (p=0.0124), and at 24 and 48 hrs (p=0.0132). But the glutamate levels were not significantly elevated in group 1.
DISCUSSION
Distal aortic perfusion and hypothermia as adjunct methods for descending and thoracoabdominal aortic aneurysm repair are theoretically effective for preventing paraplegia or paraparesis [9] . However, the risk of neurological dysfunction after descending and thoracoabdominal aortic replacement has ranged from 5% to 30%. Some patients awake from anesthesia with acute-onset paraplegia, while others develop delayed-onset paraplegia over the following 1 to 5 days [ The present study demonstrates that the administration of the noncompetitive NMDA receptor antagonist MK-801 (2 mg/kg) immediately after 24 min of spinal cord ischemia in rabbits significantly improved the neurological findings and limited the neuronal damage. In fact, our experimental results indicated that there was significant neurological improvement, with a Modified Tarlov scale 4 to 5, at 24 and 48 hrs between groups 1 and 3. However, there were no significant differences between group 1 and 3 at 12 hrs after reperfusion. The rabbits receiving MK-801 (2 mg/kg) appeared to be paraplegic at 12 hrs after reperfusion, as the higher dose of MK-801 has profound sedative effects because the higher dose administration of ''K-801 has profound sedative effects [17] . It was therefore difficult to score the neurological findings precisely. Kochhar et al. have observed a 75% increase in the duration of ischemia required to produce paraplegia in rabbits receiving the systemic administration of MK-801 (1 mg/kg) 5 min after the induction of spinal cord ischemia in the rabbit model [17] . Yum and Faden, Martinez-Arizala and colleagues have shown that delayed systemic administration with MK-801 (1 mg/kg) 5 min after reperfusion is effective in reducing neurological dysfunction in 25 min spinal cord ischemia models [6, 19] . Hypothermia reduces intracranial pressure, which in turn can limit edema formation, in addition hypothermia is effective in reducing both acute and delayed neuronal injury [20] . However, in group 2 (MK-801 1 mg/kg dissolved in hypothermic saline), there was no neurological improvement, which is contrary to the results of these previous studies. MK-801 (1 mg/kg) did not have sufficient spinal cord protective capabilities in our spinal cord ischemia model. Differences in the methods of drug administration, however, may help to explain these results. It has been shown that higher doses of MK-801 can cause side effects in some animals thatcan interfere with neuroprotection [1 7,21] . However, at the dose used in our study, we found thatMK-801 (2 mg/kg) was beneficial in our model for decreasing the effects of spinal cord ischemia.
The results of our histopathologic study confirmed the ability of MK-801 to limit neuronal damage in the anterior horn. Although normal animals had neuronal cells in the anterior horns, rabbits with paraplegia showed total destruction of the anterior horn cells with vacuolization.
Inthe tissue samples of MK-801-treated rabbits, the motor neurons were well preserved.
There were significant differences amongthree groups according to the number of surviving neurons per section. We observed a significant loss of surviving neurons in the ventral horns in group 1 (p <0.001 versus group 3). There were significantly fewer surviving neurons in group 3 than in the normal group (p=0.0017). In contrast,according to Modified Tarlov scale, the neurological scores in the MK-801 (2 mg/kg)-treated group did not significantly differ from those of the normal rabbits. These results suggested that MK-801 reduce the extensive neuronal damage without remarkable neurological dysfunction by a partial block of mechanism described by Olney's theory, in which one CNS neuron excites another CNS neuron to death [5] .
The elevation of glutamate and aspartate levels after spinal cord ischemia has been measured in the rat using microdialysis [13] and in a clinical study using cerebrospinal fluid samples [22] . In these studies, marked elevations in glutamate and aspartate above basal levels after severe spinal cord injury have been observed [13, 22] . Under physiological circumstances, most glutamate is located intracellularly, and released glutamate is rapidly taken up by astrocytes and neurons,leaving low extracellular concentrations of the transmitter [14, 1 5 ] . It appears likely that an inhibition of the reuptake systems due to severe ischemia contributes to extracellular glutamate accumulations [13] . Since trauma to the spinal cord causes a rapid disturbance in the bloodspinalcord barrier, leakage of glutamate from the blood may well occur after opening of the bloodbrain barrier, as has been reported [23, 24] . Some of these amino acids may be derived from cells of the injured cord, and leakeage of amino acids from the blood due to an opening of the blood-spinal cord barrier is also possible [13] . In our study, we did not observe any changes in glutamate levels, although we did observe changes in aspartate levels in group 1. There were significant differences in the increase rate of aspartate between 12 and 48 hrs (p=0.0124) and between 24 and 48 hrs (p=0.0132). The increase rates of glutamate and aspartate in group 3, which were observed to result in no neurological injury, showed no significant differences statistically. The increases in aspartate levels in the post ischemic period could possibly be related to the neurological outcome. It has been suggested that there is a significant glutamate release after moderate and severe spinal cord ischemic injury that results in extensive edema; no glutamate release, however, has been noted after mild injury, although this degree of compression still produces vasogenic edema [25] . In our experimental model, the grade of spinal cord ischemia was mild and moderate and other factors might be related to the neurological dysfunction occurring after mild injury.
In conclusion, we found that the noncompetitive NMDA receptor antagonist MK-801 (2 mg/kg) produced a beneficial effect in the rabbit spinal cord ischemia model when administered through an isolated aorta in the early ischemic period. MK-801 can reduce the neuronal ischemic damage and increase the tolerance of the spinal cord to ischemia. We observed an elevation of aspartate, but not glutamate levels in our rabbit model of spinal cord ischemia. The elevation of aspartate in the post ischemic period is possibly related to the postoperative neurological outcome. The causeof neurological dysfunction in the post ischemic period is maltifactorial. We now believe that neurological dysfunction is improved not only by pharmacological support but also by a reduction of risk factors based on the combination of several protective methods. 
